Colucci WS: Pharmacologic therapy of heart failure with reduced ejection fraction. UpToDate, 2016. http://www.UpToDate.com.
Colucci WS: Treatment of acute decompensated heart failure. Components of therapy. UpToDate, 2016. http://www.UpToDate.com.
Elkayam U et al: Vasodilators in the management of acute heart failure. Crit Care Med 2008;36:S95.
Fitchett DH, Udell JA, Inzucchi SE: Heart failure outcomes in clinical trials of glucose-lowering agents in patients with diabetes. Eur J Heart Fail 2017;19:43.
George M et al: Novel drug targets in clinical development for heart failure. Eur J Clin Pharmacol 2014;70:765.
Givertz MM et al: Acute decompensated heart failure: Update on new and emerging evidence and directions for future research. J Card Fail 2013;19:371.
Hasenfuss G, Teerlink JR: Cardiac inotropes: Current agents and future directions. Eur Heart J 2011;32:1838.
Lam GK et al: Digoxin antibody fragment, antigen binding (Fab), treatment of preeclampsia in women with endogenous digitalis-like factor: A secondary analysis of the DEEP Trial. Am J Obstet Gynecol 2013;209:119.
Lingrel JB: The physiological significance of the cardiotonic steroid/ouabainbinding site of the Na, K-ATPase. Annu Rev Physiol 2010;72:395.
Lother A, Hein L: Pharmacology of heart failure: From basic science to novel therapies. Pharmacol Ther 2016;166:136.
Malik FI et al: Cardiac myosin activation: A potential therapeutic approach for systolic heart failure. Science 2011;331:1439.
Marso SP et al: Liraglutide and cardiovascular outcomes in type 2 diabetes. N Engl J Med 2016;375:311.
Papi L et al: Unexpected double lethal oleander poisoning. Am J Forensic Med Pathol 2012;33:93.
Parry TJ et al: Effects of neuregulin GGF2 (cimaglermin alfa) dose and treatment frequency on left ventricular function in rats following myocardial infarction. Eur J Pharmacol 2017;796:76.
Ponikowski P et al: 2016 ESC guidelines for the diagnosis and treatment of acute and chronic heart failure. Eur J Heart Fail 2016;18:2129.
Pöss J, Link M, Böhm M: Pharmacological treatment of acute heart failure: Current treatment and new targets. Clin Pharmacol Ther 2013;94:499.
Redfield MM: Heart failure with preserved ejection fraction. N Engl J Med 2016;375:1868.
Seed A et al: Neurohumoral effects of the new orally active renin inhibitor, aliskiren, in chronic heart failure. Eur J Heart Fail 2007;9:1120.
Taur Y, Frishman WH: The cardiac ryanodine receptor (RyR2) and its role in heart disease. Cardiol Rev 2005;13:142.
Topalian S, Ginsberg F, Parrillo JE: Cardiogenic shock. Crit Care Med 2008;36:S66.
Tran HA, Lin F, Greenberg BH: Potential new drug treatments for congestive heart failure. Exp Opin Invest Drugs 2016;25:811.